| abstract |
Urine urination comprising a compound having both an acetylcholinesterase inhibitory action and an α1 antagonistic action, which exhibits an excellent action of improving bladder urination function (an action to improve urinary flow rate and urination efficiency) and does not affect urinary pressure and blood pressure The present invention relates to an agent for preventing or treating a disorder. |